期刊文献+

国产辛伐他汀的调血脂作用临床分析 被引量:7

The Lipid-regulating Effects of Domestic Simvastatin in Patients with Primary Hyperlipidemia
下载PDF
导出
摘要 目的观察国产辛伐他汀京必舒新的调血脂作用。方法将124例高脂血症患者随机分为京必舒新组60例和舒降之组64例,两组患者每日早餐后分别口服京必舒新、舒降之各10mg,用药4周及8周时检测患者血清总胆固醇(TC)、三酰甘油(TG)及高密度脂蛋白胆固醇(HDL-C)。结果京必舒新组与舒降之组患者用药4周及8周与本组用药前比较差异均有统计学意义(P<0.01)。结论国产辛伐他汀京必舒新调血脂作用疗效肯定,与进口产品舒降之比较疗效相同。 Objective To investigate the effects of domestic simvastatin on lipid metabolism in patients with primary hyperlipidemia. Methods Sixty and 64 patients with primary hyperlipidemia were randomly assigned into domestic simvastatin group ( n = 60) and imported simvastatin group ( n = 64) by lots - drawing. They were given domestic and imported simvastatin respectively, 10mg, qd for 8weeks. Serum level of total cholesterol (TC), triglyceride (TG), hydensity lipoprotein cholesterol ( HDL - C) were measured at the ends of 4 and 8 weeks of the trial period. Results Four and 8 weeks after administration of domestic simvastatin, TC was decreased by 23.4% and 28.9%, TG was decreased by 21.5% and 29.4%, HDL - C was increased by 11.8% and 15.7%. No difference was obsereved between the effects of the domestic and imported simvastatin on lipid metabolism in parients with primary hyperlipidemia. Conclusion Domestic simvastatin has satisfactory lipid - regulating effects similar to those of imported simvastatin.
作者 何庚山
出处 《实用心脑肺血管病杂志》 2009年第5期376-377,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 辛伐他汀 血脂 治疗 Simvastatin Lipid Therapy
  • 相关文献

参考文献5

  • 1刘国仗,胡大一,陶萍,诸骏仁,郭林妮,郭静萱,游凯.心血管药物临床试验评价方法的建议[J].中华心血管病杂志,1998,26(1):5-11. 被引量:1439
  • 2Tikkanen MJ,Laakso M,Ilmonen M,et al.Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM.A multicenter comparison study[J].Diabetes Care,1998,21:477-481.
  • 3Schoonjans K,Peinado OJ,Fruchart JC,et al.3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-Ⅲ and lipoprotein lipase[J].FEBS lett,1999,452:160-164.
  • 4王顺先,赵红宁.阿托伐他汀钙对短暂性脑缺血发作患者颈动脉粥样硬化斑块和血脂的影响[J].中国全科医学,2008,11(23):2175-2176. 被引量:17
  • 5黄志华 李平 钟秀华 等.阿托伐他汀对不稳定型心绞痛病人血脂及C -反应蛋白水平的影响.实用心脑肺血管病杂志,2007,15:453-453.

二级参考文献13

  • 1曾波.短暂性脑缺血发作治疗63例疗效观察[J].中国误诊学杂志,2006,6(3):448-449. 被引量:3
  • 2杜书章,岳晓红,杨国杰,张晓坚,康建.阿托伐他汀治疗高血压患者动脉粥样硬化[J].医药论坛杂志,2006,27(8):17-18. 被引量:23
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33009
  • 4何坪,殷跃辉.阿托伐他汀对血管保护作用的研究进展[J].中国全科医学,2007,10(16):1390-1392. 被引量:33
  • 5[6]Grundy SM,Clemen JL,Mers CN,et al.Implication of recent clinical trials for the national cholesterol education program adult treatment panel Ⅲ guideline[J].Circulation,2004,110(2):227-230.
  • 6[8]Roivainen M,Kajander MV,Palosuo P,et al.Infections,Inflammation,and the risk of coronary heart disease[J].Circulation,2000,101(3):252-259.
  • 7[9]Downs JR.Clearfield M,Whitney E,et al.Primary prevention of acute coronary events with lovastatin in men and women with average choresterol levels[J].JAMA,1998,279(20):1615-1622.
  • 8[11]Rutishauser J.The role of statins in clinical medicine.LDH-cholesterol lowering and beyond[J].Swiss Med Wkly,2005,136(7):41-49.
  • 9[12]Castilla GL,Del C,Lopez C,et al.Statins in stroke prevention:What an internist should know[J].Eur J Intern Med,2008,19(1):8-14.
  • 10[13]Amarenco P,Labreuche J,Lavallee PH,et al.Statins in stroke prevention and carotid atherosclerosis[J].Stroke,2004,35(12):2902-2909.

共引文献1453

同被引文献50

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部